m2p-labs, a Baesweiler, Germany-based provider of innovative screening and fermentation technologies for the pharmaceutical, biotechnical and chemical industries, has received an investment of undisclosed amount.
Backers include the Seed Fund for the Region of Aachen GmbH & Co. KG, the KfW with the ERP Start-Up Fund and the High-Tech-Gründerfonds, as well as two private investors.
The company intends to use the funds to expand sales efforts, to promote the technological development of new products and to launch in the market. m2p-labs plans to add experienced sales representatives in the second half of 2011.
Led by managing director Dr. Frank Kensy, managing partner Carsten Müller, the company specializes in the development of process solutions for cell culture and microbiology in micro-litre scale. The first marketable development is a miniature bioreactor system for high content screening.
m2p-labs recently moved from Aachen to the International Technology and Service Centre in Baesweiler.